Common Shared Pathogenic Aspects of Small Vessels in Heart and Brain Disease

Area of Science:

• Cardiovascular Science
• Neurology
• Vascular Biology

Background:

• Small-vessel disease (SVD), also termed microvascular endothelial dysfunction, affects cardiac and cerebral blood flow.
• Cardiac SVD impairs small vessel function, leading to ischemia and cardiac events, independent of coronary artery disease (CAD).
• Cerebral SVD manifests as silent subcortical vascular burden, including lacunar-ischemic events and white-matter hyperintensities.

Purpose of the Study:

• To review the current understanding of small-vessel disease (SVD) affecting the heart and brain.
• To highlight diagnostic methods and inflammatory markers associated with SVD.
• To discuss the challenges and limitations in SVD therapeutic strategies.

Main Methods:

• Literature review focusing on small-vessel disease (SVD) in cardiac and neurological contexts.
• Analysis of diagnostic imaging techniques for SVD.
• Examination of inflammatory markers and oxidative stress indicators relevant to SVD.

Main Results:

• SVD significantly impacts cardiac and brain health, leading to ischemia and neurological deficits.
• Inflammatory markers (e.g., C-reactive protein, TNF-α, IL-6) and oxidative stress are implicated in SVD.
• Diagnostic imaging is crucial for identifying cardiac and brain SVD.
• Investigational therapies, including antioxidants, have yielded unsatisfactory outcomes.

Conclusions:

• Small-vessel disease (SVD) presents a significant clinical challenge due to its impact on major organs and limited therapeutic options.
• Effective diagnosis relies on advanced imaging techniques.
• Current treatment strategies for SVD are largely supportive, utilizing traditional anti-ischemic and risk-reduction therapies for CAD.